Has the arrival of GLP-1 agonists modified the administration of OSA? We talk about the trials and the truth.
00:38 Introduction to the subject and introducing Dr. Eric Olson
01:17 Tirzepatide: first drug that’s FDA accepted for the therapy of OS
03:51 Where these constructive outcomes dependant on weight reduction?
05:11 Do you are expecting that insurances will cowl tirzepatide?
06:53 Should the sleep specialist be prescribing tirzepatide?
09:24 Atomoxetine and oxybutynin: Do these brokers workK
11:18 Final messages
From Mayo Clinic to your inbox, sign-up without cost: https://mayocl.in/3e71zfi
Visit Mayo Clinic: https://mayocl.in/2COVmlm
Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/
Follow Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/
Follow Mayo Clinic on X, previously Twitter: https://x.com/MayoClinic
Follow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic
